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Summary Human Platt neuroblastoma cells were transfected with the marker gene, bacterial lacZ, to track
cells at the earliest stages after ectopic injection at two different sites in athymic nude mice. Three clones
(LZPt-1,-2 and -3) of differing morphologies were analysed. All clones yielded large primary tumours
subcutaneously or intradermally with similar latency. While LZPt-2 and -3 clones generated well-staining
primary tumours, LZPt-l cells yielded many non-staining tumours, indicating greater instability of lacZ
expression for this clone in situ (stability of lacZ expression in culture was similar for all three clones). After
s.c. or intradermal injections, tumour cells were tracked for 1 h to >3 weeks (palpable) to evaluate the
topology and population expansion characteristics at the earliest times. From 1 h to 2 days, tumour cells were
concentrated in central masses with 'crinkly hair' distributions emanating from the periphery. Between 3 and 7
days, these 'crinkly hair' patterns were cleared from the tissue, leaving dense ovoid patterns of tumour cells.
These concentrations of cells expanded collectively, not by division of one or a few cells, but by division of
many cells. For elone LZPt-1, cells stained well with X-gal for 2-3 days; by 7 days, most cells were
non-staining. Evidence suggests that lacZ expression is turned off in these tumour cells, rather than a lacZ-
cell type clonally dominating the population. For all three clones, tumour cells remained rounded and did not
spread in any tissue environment at all time points, indicating very different matrix adhesion mechanisms
operating in situ compared with their distinctive spreading patterns in culture. Angioneogenesis near primary
tumours became evident by 2-3 days, leading to extensive vascularisation by 1-2 weeks. Overall, these studies
indicate common tumour progression characteristics for three different clones of human neuroblastoma,
insight into lacZ instability mechanisms operating in one of these clones and the earliest events in primary
tumour formation for this tumour at two different ectopic sites.
Progression of human neuroblastoma tumours from the
initial stage of transformation of an embryonic precursor cell
in the neural crest to advanced stages of metastasis in the
nervous system, the adrenal gland and bone marrow has not
been well studied in many regards (Brodeur et al., 1988;
Gilbert et al., 1988; Brodeur & Moley, 1991; Moss et al.,
1991; Thiele, 1991). Little is known about clonal selections
that occur at various stages of tumour progression, the
routes of tumour cell spread during metastasis, critical genes
required for progression, extracellular matrix mechanisms
important in these 'events and host cell populations that
promote or inhibit these processes. Analyses of extracellular
matrix adhesion of neuroblastoma cells in culture revealed
mechanisms distinct from those seen in many other cell types.
Neuroblastoma cells recognise sequences on fibronectin
different from most untransformed cells that have conven-
tional integrin and heparan sulphate proteoglycan receptors
(Mugnai et al., 1988; Culp & Barletta, 1990; Culp et al.,
1991). These tumour cells can be missing many of the com-
mon integrin subunits (Favrot et al., 1991; Yoshihara et al.,
1991, 1992) and in other cases have a unique form of the PI
subunit (Dedhar & Gray, 1990). Some neuroblastoma cells
express the integrin M4Al (Haugen et al., 1990; Bednarczyk &
McIntyre, 1992), used by some lymphoid cell classes for cell
recognition functions but not by most adherent cells in the
body; this integrin appears in an altered form in some cases
(Bednarczyk & McIntyre, 1992). Some adhesion properties in
culture correlate with metastatic spread in situ (Hutchinson et
al., 1989).
To relate the significance of findings in culture model
systems to actual tumour progression and metastasis pro-
cesses in situ, human neuroblastoma cells must be identifiable
in host organs in a nude mouse experimental system. To
facilitate detection of tumour cells at the single-cell level, our
laboratory developed use of the bacterial lacZ gene, trans-
fected into ras-transformed fibroblasts, as a genetic and
histochemical marker to track fibrosarcoma cells staining
intensively blue upon X-gal treatment (Lin et al., 1990a, b).
Alternative histochemical marker genes - Drosophila alcohol
dehydrogenase or human placental alkaline phosphatase -
were also developed to genetically tag two or more tumour
cell classes to evaluate metastatic co-routing in virtually any
host tissue (Lin & Culp, 1991). Co-injection of ras- or sis-
transformed fibroblasts, tagged with different histochemical
marker genes, demonstrated intercellular cooperation during
the earliest events in experimental metastasis by two closely
related tumour cell derivatives (Lin et al., 1992, 1993), as well
as insight into some aspects of tumour cell clearance in target
organs (Lin et al., 1990b; Lin & Culp, 1992a). The lacZ
marker gene has now been used to tag breast carcinoma cells
(Brunner et al., 1992), melanoma cells (Dooley et al., 1993)
and glioblastoma cells (Lampson et al., 1993), as well as to
track therapeutic 'targeting' genes to tumour cell populations
in situ (Vile & Hart, 1993).
In these studies, we analyse the earliest fates of human
neuroblastoma cells injected into athymic nude mice at two
different ectopic sites using the bacterial lacZ marker gene
transfected into cells. Three stably expressing clones with
morphologies characteristic of N-type, S-type and I-type
neuroblastoma cells were studied (Rettig et al., 1987; Cic-
carone et al., 1989). These analyses demonstrate several
important findings with regard to the fates of injected cells
and expansion of tumour cell populations with time at
ectopic sites, including different matrix recognition in situ
from those in culture and utility of the lacZ marker gene to
evalute genetic instability in tumour cell populations during
their expansion.
Materials and methods
Generation ofLZPt cell lines
Cells, free of Mycoplasma, were grown in Dulbecco's
modified Eagle medium supplemented with antibiotics and
10% neonatal calf serum. Human Platt neuroblastoma cel1s
(Kemshead et al., 1980) were transfected with the pRSV/lacZ
plasmid, which also codes for the neoR gene using the calcium
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phosphate protocol (Lin & Culp, 1991) under conditions
which maximise expression of the bacterial marker gene (Lin
et al., 1990a,b). Stably transfected/expressing cells were
selected with G418 in the medium and G418-resistant col-
onies tested for lacZ expression, i.e. staining intensively blue
with X-gal treatment. High-expressing colonies were cloned
twice sequentially to generate three cloned populations (abb-
reviated to LZPt-1, -2, and -3 and selected for morphological
criteria and for their uniform lacZ expression, as determined
both by blue staining with X-gal substrate and by FACS
using fluorescein digalactoside substrate uptake and conver-
sion in living cells; Lin & Culp, 1992b). Non-transfected
tumour cells failed to stain at all. LZPt clones harbour one
copy of the lacZ gene and in culture remain uniformly
stainable with X-gal for > 15 passages; they gradually lose
stainability with continuous culture over long periods of time
by overgrowth of lacZ-non-expressing variants. For tumour
analyses, all cells were used within 15 culture passages of
isolation.
Animal tumour studies
Animal use was approved by the Animal Care and Use
Committee of Case Western Reserve University and executed
in the AAALAC-accredited Athymic Animal Facility.
Athymic nude mice (NIH nu/nu; 4-6 weeks old) were
injected at indicated sites with 1 x 105 cells in phosphate-
buffered saline (PBS). Each clone of tumour cells was
injected at two sites per mouse (bilaterally and symmetrically)
s.c. or intradermally; these sites included the hypochondriac,
lateral and inguinal regions of the abdomen. For s.c. or
intradermal injections, mice were anaesthetised with ketamine
hydrochloride (200 mg kg-') and acetylpromazine
(2 mg kg-') intraperitoneally prior to cell injection. Tumour
cells were injected s.c. in 0.1 ml of PBS; intradermal injec-
tions used 0.025 ml of PBS-suspended cells. To identify injec-
tion sites easily, skin was tattooed intradermally with two
foci of India ink particles flanking the injection site; tattoos
persisted for periods in excess of 6 weeks. Mice were killed at
the indicated time points by overdose of pentobarbital
administered i.p. When the mice reached a surgical plane of
anaesthesia, the thorax was opened and 5 ml of fixation
solution [2% (v/v) formaldehyde/0.2% (v/v) glutaraldehyde
in PBS] was injected slowly into the left ventricle of the heart
while the right ventricle was incised to permit drainage. Skin
and body wall sites of the ventral abdomen encompassing the
India ink tattoos were harvested as a unit and placed in
additional fixation solution for 12-24 h.
Preparation oftissuesfor staining
After fixation, skin samples and internal organs were stained
for lacZ activity immediately (Lin et al., 1990a, b). Skin sites
with adherent body wall tissue were divided along the ventral
midline prior to staining. One-half of each tissue, containing
one injection site for each clone, was split along the sub-
cutaneous fascial plane separating the skin from the underly-
ing body wall. The opposite half containing a second set of
injection sites was cut, using the India ink spots as a guide,
into approximately 1-cm-diameter pieces, each of which
included an injection site, associated skin, subcutaneous
space and adjacent body wall tissue. For transverse sections,
each of these pieces was also cut with a scalpel blade at the
midpoint between India ink tattoos to traverse the site of
injection.
Histochemical staining oftissues
All cultured cells and tissues were histochemically stained for
bacterial P-galactosidase activity after glutaraldehyde/
formaldehyde fixation as previously described (Lin et al.,
1990a, 1992). Cultured cells and tissues were incubated at
3TC for 12-24 h in stain solution: 1 mgml-' X-gal, 20 mM
potassium ferricyanide, 20 mM potassium ferrocyanide, 2 mM
magnesium chloride in PBS. Organs from animals not injected
with LZPt cells failed to stain by this protocol. Photomicro-
graphs of organs and tissue specimens were obtained with a
Nikon SMZU dissecting microscope equipped with a
Microflex UFX using Fujichrome 64T film.
Materials
Culture flasks and cluster dishes were purchased from Becton
Dickinson Labware (Oxnard, CA, USA); neonatal calf serum
from Biologos (Naperville, IL, USA); Dulbecco's modified
Eagle medium and G418 from Gibco (Grand Island, NY,
USA); X-gal-(5-bromo-4-chloro-3-p-indoyl-D-galactopyrano-
side) and fluorescein digalactoside from Research Organics
(Cleveland, OH, USA); Permount and acetone from Fisher
Scientific (Fairlawn, NJ, USA); glutaraldehyde from Eastman
Kodak (Rochester, NY, USA); potassium ferricyanide, potas-
sium ferrocyanide, paraformaldehyde, and formaldehyde
from Sigma (St, Louis, MO, USA); ketamine hydrochloride
and acetylpromazine from Fort Dodge Laboratories (Fort
Dodge, IA, USA) and Ayerst Laboratories (New York, NY,
USA) respectively; and pentobarbital from Ganes Chemicals
(Pennsville, NJ, USA).
Results
In vitro characteristics ofLZPt clones
Three LZPt clones gave different morphologies in culture
that persisted over the lifespan of experimental use (approx-
imately 15 passages; data not shown). They had very high
percentages of lacZ marker gene expression (>98% of cells
assayed) during these passages using either X-gal staining to
identify blue-staining cells under the light microscope or the
substrate fluorescein digalactoside, whose product is detec-
table by FACS above the background intrinsic fluorescence
of Platt cells (Lin & Culp, 1992b). LZPt-I cells display an
astrocytic morphology (Sugimoto et al., 1988) with many
short extending processes, resembling S-type neuroblastoma
cells (Rettig et al., 1987; Ciccarone et al., 1989); LZPt-2 were
highly biopolar and neuritogenic, resembling N-type cells;
and LZPt-3 cells were heterogeneous in their morphology,
containing a sizeable fraction of neuritogenic cells but also
well-spread and astrocytic cells and can be classed as I-type
cells (Rettig et al., 1987; Ciccarone et al., 1989).
Tumorigenicity at the subcutaneous site
It was first determined whether these three clones were
tumorigenic at all in athymic nude mice. Each clone was
injected s.c. and the size of tumour measured with time. For
all three clones, latency of tumour detection varied from 25
to 30 days; all injected animals yielded tumours; and all foci
grew rapidly into large tumours (>1 cm diameter) at all s.c.
injection sites.
Expression of the lacZ marker gene was evaluated in large
tumours (Figure 1). LZPt-2 cells yielded tumours completely
stainable for lacZ, except where necrosis of the tumour was
occurring (Figure la). The same was true for LZPt-3 cells
(Figure lb). For both clones, virtually all tumours retained
lacZ expression throughout the lifespan of primary tumour
development at the s.c. site. Retention of red cells in blood
vessels during fixation of tissues permitted orientation of
dermal blood vessels to sites of tumour development (Figure
Id and below). In addition, when s.c. tumours were carefully
teased away from their locations at the surface of the animal,
X-gal staining of the body wall side of the dermis revealed
small populations of tumour cells generating 'footprints' of
tumour that were implanting at the edge of the dermis
(Figure Id), including both large pools of tumour cells and
small collections that were too numerous to count. Therefore,
expression of the marker gene can be used to track tumour
cell populations as they invade neighbouring tissues.
For LZPt-I cells, a different result was obtained in most
(but not all) large primary tumours. Most tumours failed to672 N.R. KLEINMAN et al.
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Figure 1 lacZ marker gene activity in large primary tumours. Each of the LZPt clones was injected into nude mice s.c. and
primary tumours allowed to grow to diameters greater than 5 mm (rulers show 1 mm segments in a-c). These tumours and
adjoining host tissue were harvested and stained with X-gal to identify regions of tumour where lacZ gene activity could still be
detected. a, LZPt-2 tumour showing uniform X-gal staining throughout the tumour, except in some focal regions in the centre
where necrosis was developing (magnification 35 x). b, LZPt-3 tumour showing uniform X-gal staining (magnification 35 x). c,
This is an example of an LZPt-I tumour in which most of the tumour fails to stain with X-gal (broad arrow in c) while a small
population of tumour cells concentrated in one region of the tumour do stain (open arrow in c) (magnification 110 x). d, A large
subcutaneous LZPt-3 tumour was separated from the overlying skin of the animal and the skin was stained with X-gal to test for
the presence of tumour cells (magnification 120 x). (In animals not injected with tumour cells, the dermis was completely
non-stainable.) Two different patterns of 'footprints' of tumour are shown on the dermal side of the subcutaneous space. Large
collections of tumour cells are observed (large arrowheads), while small focal collections are numerous as 'footprints' (small
arrowheads). Blood vessels are also very apparent throughout the dermis.
stain with X-gal when they had grown large (Figure Ic),
indicating either that the lacZ gene was being turned off in a
large fraction of these cells or that a variant clone, not
expressing lacZ, was dominating this tumour at a very early
time point (see below). It was also noted in large non-
staining LZPt-1 tumours that small populations of stainable
tumour cells could still be observed (open arrow in Figure
Ic). Therefore, there are marked differences in stability of
lacZ expression and/or clonal selectivity during primary
tumour formation when comparing clone 1 with clone 2 or 3
cells (see below). The same characteristics of primary tumour
development were observed when these clones were injected
intradermally.
Earliest stages ofprimary tumour development at two ectopic
sites
Expression of lacZ permits detection of single tumour cells at
virtually any organ site (Lin & Culp, 1992b). We take advan-
tage of this sensitivity for tracking the development of
primary tumours at the subcutaneous and intradermal sites
for all three clones to determine the nature and extent of cell
population expansions that occur at these earliest times. It
should also provide indication as to how LZPt-1 primary
tumours become enriched with lacZ non-expressing cells.
Figure 2 illustrates the distribution of LZPt-3 tumour cells
at these two injection sites with time. As early as 1 h post
injection, tumour cells are concentrated into a large mass of
cells with some projections of cells, referred to as 'crinkly
hair' distributions, that extend into host tissue sites along
pathways of least resistance (Figure 2al and a2). By 48 h
(Figure 2bl and b2), these 'crinkly-hair' patterns are disap-
pearing as a result of either clearance of tumour cells from
host tissues or tumour cell migration back toward the central
tumour mass. The former possibility is indicated by two
pieces of evidence - lysis of these peripheral cells is evident
with release of blue product into intercellular spaces and the
absence of any polarity of cell movement (see below on this
point). At intradermal sites, the topographical relationships
between tumour cell populations and endogenous blood
vessels is also apparent at these very early time points (Figure
2a2 and b2).
By 1 week, 'crinkly-hair' projections were completely
absent (Figure 2cl and c2) and the large number of cells in
the central mass appeared to be expanding, not by division of
one or a few cells but by division of many cells. Therefore,TUMOUR PROGRESSION OF NEUROBLASTOMA 673
clearing of tumour cells at injection sites may be limited, and
highly diluted tumour cells at the periphery are cleared most
effectively. By 3 weeks, just before tumours become palpable,
LZPt-3 sites had developed into large ovoid structures result-
ing from division of a large number of cells in the central
mass. In all cases, there was no evidence that only one or a
few cells were dividing to give rise to the primary tumour;
rather, a very large number of cells were dividing to give rise
to the tumour mass. In a few cases with LZPt-3, intradermal
tumours were developing regions where the lacZ gene was
not being expressed (arrowhead in Figure 2d2), a situation
not noted for this clone at the subcutaneous site.
Tumours at intradermal sites were consistently associated
with the dermis and did not spread across the subcutaneous
space. In contrast, s.c. injections led to cell association ('foot-
prints') with the dermal side of this space (e.g. Figure Id), and
Cl
Figure 2 Time course of early primary tumour formation at two sites. LZPt-3 cells (10) were injected either into subcutaneous
sites identified by two intradermal spots of India ink particles for ease of identification (series I micrographs) or intradermally
between the India ink spots (series 2 micrographs). Mice were then sacrificed at the indicated time points and skin/subcutaneous
samples harvested as described in Materials and methods. a,, One hour post subcutaneous injection, dermis and associated subcutis
(magnification 32 x). a2, One hour post intradermal injection, dermis and associated subcutis (magnification 32 x). b,, Forty-eight
hours post subcutaneous injection, dermis and associated subcutis (magnification 32 x). b2, Forty-eight hours post intradermal
injection, dermis and associated subcutis (magnification 32 x). cl, One week post subcutaneous injection, external abdominal
oblique muscle, fascia and associated subcutis (magnification 43 x). c2, One week post intradermal injection, dermis and associated
subcutis (magnification 43 x) dl, Three weeks post subcutaneous injection, external abdominal oblique muscle and parietal
peritoneum (magnification 43 x). d2, Three weeks post intradermal injection, dermis and associated subcutis (magnification 43 x).
Small arrowheads in photomicrographs a,, a2, b, and b2 indicate 'crinkly-hair' patterns of multiple projections of tumour cell
populations evident during the first 48 h of residence in these tissue sites. Small solid arrows in a2, b2 and c2 indicate small dermal
blood vessels. Large solid arrows in b2, c2 and d2 indicate larger dermal blood vessels. Open arrows in a, and a2 identify intradermal
India ink spots. Large arrowhead in d2 labels area of a 3 week intradermal tumour with decreased lacZ expresion, a phenomenon
that is rare in large subcutaneous tumours using LZPt-3 cells.674 N.R. KLEINMAN et al.
by 1 week tumour expansion was associated with the fascia
of the abdominal wall musculature. At intradermal injection
sites, it was also common to observe tumour cells collected
around blood vessels (e.g. Figure 2b2). These same early
events were observed for LZPt-2 cells at both s.c. and int-
radermal sites (not shown).
Another perspective on early events was provided by trans-
verse sectioning of the skin at the midline between the India
ink tattoos, as shown in Figure 3 for LZPt-3 cells [the same
findings with LZPt-2 cells (not shown)]. Transverse sections
demonstrate accurate localisation of the injected tumour cells
to the s.c. site (series 1 of Figure 3) or intradermal site (series
2). Because of the sensitivity of lacZ stainability, this app-
roach provides appreciation for progression of primary
tumours from early stages with 'crinkly hair' distributions
(e.g. Figure 3al and a2), through the stage of consolidation
and elimination of peripheral cells by 1 week (Figure 3bl and
b2), to the generation of a single spheroid tumour mass by 3
weeks (Figure 3cl and c2). It also confirms that many
tumour cells are dividing to give rise to the central tumour
mass. It is also evident that tumour cells injected at the s.c.
site do not invade the dermis at early time points; also, these
cells injected intradermally do not traverse the subcutaneous
space.
LZPt-I cells are unique in that they generate large tumours
consisting almost entirely of lacZ non-expressing cells (Figure
ic). The basis for this was investigated by tracking the
distribution of expressing and non-expressing cells (Figure 4).
In Figure 4a, b, e and f, LZPt-1 cells at intradermal sites are
stainable with X-gal for periods greater than 48 h and display
the 'crinkly-hair' distributions observed for the other two
clones. However, by 1 week post injection (Figure 4c), the
pattern of staining has changed dramatically under condi-
tions in which the cell population has expanded only to a
limited extent. X-gal staining is very weak in most tumour
cells, with a diffuse blue pattern in the tissue as if lacZ
expression is being turned off synchronously in most of the
population (large arrowheads in Figure 4c). Only a few
Figure 3 Transverse sections of LZPt-3 subcutaneous and intradermal tumours. Cells were injected as described in the legend to
Figure 2 and Materials and methods. At the indicated times following subcutaneous (series I micrographs) or intradermal (series 2
micrographs) inoculation, animals were sacrificed and the injection sites were harvested. Transverse sections through epidermis,
dermis, subcutis, abdominal wall musculature and parietal peritoneum were performed at the midline between the two India ink
spots. a,, One hour post subcutaneous injection (magnification 87 x). a2, One hour post intradermal injection (magnification
130 x). bl, One week post subcutaneous injection (magnification 174 x). b2, One week post intradermal injection (magnification
43 x). c,, Three weeks post subcutaneous injection (magnification 87 x). c2, Three weeks post intradermal injection (magnification
43 x). Double-arrowed lines demarcate the extent of the epidermis and dermis in a, and a2; large open arrows identify the ventral
abdominal musculature.TUMOUR PROGRESSION OF NEUROBLASTOMA 675
well-staining LZPt-l tumour cells are observed at this site at
1 week even though the site is composed of many thousands
of cells (small arrowhead in Figure 4c). These results indicate
that the expression of this marker gene in this particular
clone is turned off by day 7 in most, but not all, tumour
cells. By 3 weeks (Figure 4d and h), non-expressing cells have
expanded in number and are contributing to the vast
majority of tumour mass just prior to palpability. An excep-
tion to this pattern of non-stainable LZPt-1 tumours is
shown in Figure 4g, in which the 1-week-old tumour retains
some stainability.
During these analyses, earliest evidence for tumour-
induced angiogenesis occurred at the 48 h time point, partic-
ularly at well-vascularised intradermal sites. In Figure 5a,
numerous small blood vessels are branching both towards
and away from the LZPt-3 tumour cell mass, originating
from a major blood vessel near the injection site. These small




Figure 4 Loss ofP-galactosidase activity of LZPt-l cells at early time points. Photomicrographs a-d show dermis and associated subcutis, while photomicrographs e-h are transverse sections through epidermis, dermis, subcutis, abdominal wall musculature and parietal peritoneum at the midline between India ink spots. a, One hour post intradermal injection (magnification 32 x). b, Forty-eight hours post intradermal injection (magnification 43 x). c, One week post intradermal injection (magnification 43 x). d.
Three weeks post intradermal injection (magnification 43 x). e, One hour post intradermal injection (magnification 43 x). f, Twenty-four hours post intradermal injection (magnification 43 x). g, One week post intradermal injection (magnification 43 x). h, Three weeks post intradermal injection (magnification 43 x). Small arrowheads in a and b indicate the 'crinkly-hair' effect of projections of tumour cell populations from the central mass of cells evident during the first 48 h of residence. Open arrows in a, b and e identify intradermal India ink spots. Large black arrowheads in c, d and h delineate the margins of poorly staining to non-staining regions of tumour; small black arrowheads in the same three photomicrographs identify very small foci of
lacZ-expressing cells.
F-
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where tumour cells are not resident, suggestive of tumour cell
induction of these smallest vessels. Alternatively, these vessels
may exist at all sites but cannot be readily observed by these
microscopic procedures unless they expand into larger vessels
in proximity to tumour cells. At 2 weeks post-injection,
larger vessels appear to be feeding the LZPt-3 tumour and to
penetrate the tumour mass (Figure Sb). By 3 weeks, many
blood vessels course over the surface of a LZPt-l tumour as
well (Figure Sc). Again, this 3-week-old LZPt-l tumour has
lost most of its stainability with X-gal, with the exception of
a small area labelled by the white open arrow (Figure Sc) in
which lacZ-expressing cells persist. These development pat-
Figure 5 Promotion of angiogenesis at early tumour cell foci.
LZPt cells were injected intradermally or subcutaneously as
indicated and tissues harvested for staining with X-gal. a, LZPt-3
cells 48 h post intradermal injection (magnification 87 x). b,
LZPt-3 cells 2 weeks post intradermal injection (magnification
87 x). c, LZPt-1 cells 3 weeks post subcutaneous injection
(magnification 43 x). Small black arrows in all photomicrographs
indicate small blood vessels that appear to be induced at the
periphery of the primary tumour at these early time points. Large
black arrows identify large blood vessels from which small vessels
originate. Large solid arrowhead in c labels area of lacZ non-
expression in 3 week tumour of LZPt-1 cells while the white open
arrowhead indicates a small region of persistent stainability.
terns for blood vessels at the peripheries of tumours were
noted for all three clones.
High resolution analyses on the Nikon SMZU microscope
permitted evaluation of the morphologies of individual
tumour cells. At earliest times, cells of all three clones at
both injection sites were very rounded with minimal
spreading in tissues, even though they spread well in culture
at these times. Figure 6a illustrates this rounded morphology
for LZPt-l cells at 24 h at the s.c. site and Figure 6b for
LZPt-3 cells 48 h at the intradermal site as they surround a
major blood vessel. By 3 weeks when most of the LZPt-l
tumour had become non-expressing for lacZ, a few lacZ-
expressing cells were observed to extend neurite-like processes
in the tumour mass (small arrow in Figure 6c). In contrast,
most of the LZPt-3 cells in a 2-week-old tumour persisted in
their round morphology (Figure 6d). These results indicate
that neuroblastoma cell-matrix interactions are very different
in situ than they are in culture.
Discussion
This study demonstrates that human neuroblastoma cells can
be stably transfected with the bacterial lacZ gene, providing
a histochemical marker to track tumour cells in any organ at
the single-cell level. lacZ expression was stable in all three
clones in culture for > 15 passages. In contrast, early-passage
LZPt-l cells yielded non-staining primary tumours in many,
but not all, cases, while LZPt-2 and -3 clones yielded uni-
formly staining tumours, similar to lacZ-transfected fibrosar-
coma cells (Lin et al., 1990a, 1993). Therefore, lacZ affords
the opportunity to evaluate instability in marker gene expres-
sion for tumour cells both quantitatively and qualitatively
and by comparing in vitro-grown populations with tumour-
progressing populations in situ.
Neuroblastoma clones of three different morphologies (N-,
S- and I-type cells; Rettig et al., 1987; Sugimoto et al., 1988;
Ciccarone et al., 1989) display tumorigenicity in nude mice at
s.c. sites similar to parental cells. At both s.c. and intrader-
mal sites ectopic for neuroblastoma, all three clones yielded
similar latency times and similar kinetics of primary tumour
development. During expansion of s.c. tumours, small
populations of tumour cells, referred to as 'footprints',
developed on the dermal side of the s.c. space, demonstrating
the earliest stages of primary tumour invasion of neighbour-
ing tissues (Hagiwara et al., 1993). Overall, these studies
reveal many similarities and only a few subtle differences in
the tumour progression characteristics among N-type, S-type
(or Schwannian-type cells; Sugimoto et al., 1988) and I-type
cells.
lacZ enabled visualisation of tumour cells at earliest times
after s.c. or intradermal injections to evaluate how cells
localise in tissues, if and where tumour cell clearance occurs
and how populations yield a palpable tumour. All three
clones at both injection sites yield 'crinkly-hair' patterns at
their edges for 2-3 days, presumably by cells penetrating
along paths of least resistance in the host tissue. Tumour
cells are then consolidated into concentrated populations by
7 days. Several pieces of evidence indicate that these 'crinkly-
hair' populations are cleared from the tissue and that tumour
cells do not migrate back towards the central tumour mass.
These cells fail to spread their cytoplasm in tissues or reveal
any polar migration pattern. Tumour cells in the 'crinkly-
hair' also yield some diffuse blue stain spreading through the
tissue, characteristic of tumour cell lysis (this was not
observed after the consolidation phase). These results
indicate some degree of tumour cell density dependence for
survival. In this regard, neuroblastoma cells have been shown
to be susceptible to neutrophil-mediated lysis (Barker &
Reisfeld, 1993).
This LZPt-I system was particularly effective for visualis-
ing morphologies of individual tumour cells at all stages of
primary tumour evolution. Most cells of all three clones
maintain a rounded morphology devoid of neuritic processes
or cytoplasmic spreading at all time points. The absence ofTUMOUR PROGRESSION OF NEUROBLASTOMA 677
a
Figure 6 Cellular morphology at high resolution during primary tumour development. Each of the three LZPt clones was injected
intradermally or subcutaneously as indicated. At various times, injection sites and adjacent tissues were harvested, fixed and stained
with X-gal. Tumour cells at the margins of tumour development were then photographed at very high magnification on the SMZU
microscope to evaluate the morphologies of single cells. a, LZPt-1 cells 24 h post s.c. injection (magnification 326 x). Well-rounded
cells are evident throughout the tissue (e.g. at the arrow). b, LZPt-3 cells 48 h post intradermal injection (magnification 326 x).
Well-rounded tumour cells (e.g. at the arrow) appear to surround this major blood vessel. c, LZPt-l cells 3 weeks post intradermal
injection (magnification 326 x). While most tumour cells are non-staining (large arrowhead), a few tumour cells do stain for lacZ,
some of which extend neurite processes in the tumour (small arrow). d, LZPt-3 cells 2 weeks post s.c. injection (magnification
652 x). Virtually all tumour cells remain rounded (e.g. small arrow) at all locations in this growing tumour.
spreading in situ, compared with their spreading into N-, S-
and I-type cells in culture (Rettig et al., 1987; Ciccarone et
al., 1989), provides further evidence for the distinctive
tumour cell-matrix adhesion mechanisms operating in host
tissues (Culp et al., 1991). In a few select cases, neurite
extension of a few LZPt-I cells could be observed in large
primary tumours. This high-resolution system should permit
more effective dissection of expression of specific genes
associated with growth regulation of these tumour cells at
their in situ locations. Some studies with melanoma cells
demonstrate that integrin expression patterns change
significantly at various stages of tumour progression (Albelda
et al., 1990).
Finally, the primary tumour cell population expands
significantly between 1 week and 3 weeks, when tumours
become palpable. This raises the issue of clonal expansion of
tumour cells to give rise to overt primary tumours. There was
no evidence throughout this phase for only one or a few cells
dividing to give rise to a clonally dominant population, as
indicated in drug resistance marker selection studies in a few
other tumour systems (Kerbel, 1990). Moreover, studies
using gene markers have established in other tumour systems
the clonal, phenotypic and genetic complexity of primary
tumour populations during progression (Heppner & Miller,
1983; Miller & Heppner, 1990; Radinsky & Culp, 1991;
Matsumura & Tarin, 1992; Moffett et al., 1992).
Evaluation of LZPt-1 tumour development provided
insight into how these tumours become non-stainable by
tracking the distribution of lacZ-expressing and non-
expressing cells with time. Expression of the marker gene in
this particular clone is lost by day 7 in most, but not all,
tumour cells. These results indicate that non-stainability of
LZPt-1 primary tumours cannot be explained by one cell
losing expression of lacZ and subsequently overgrowing all
its stainable neighbours; foci at 7 days are slightly larger than
foci at 2 days and there would be insufficient time for one or
a few non-staining cells to grow into such a large population.
Rather, most cells become non-stainable apparently by some
gene down-regulation mechanism that may be indicative of
complex environmental control over gene expression in
LZPt-1 cells, as suggested in other tumour systems (Kjon-
niksen et al., 1991; Aslakson & Miller, 1992; Hart & Saini,
1992; Nicolson, 1993).
Some insight into the earliest stages of tumour-induced
angiogenesis were also revealed. Transcardial perfusion of
fixation solution at euthanasia provided good resolution of
blood vessels with their haemoglobin-containing cells and
obviated the need for special endothelial cell staining.
Angiogenesis was best visualised with intradermal tumours as
the density of blood vessels is far greater in the dermis than
in the hypodermis. Two days post injection was the earliest
time that angioneogenesis could be observed; multiple small
vessels, originating from larger dermal blood vessels in the
vicinity of the injection site, were noted branching toward the
tumour cell mass. By 1 week post injection, the vessels
growing in the direction of the tumour had enlarged, while
those growing in the opposite direction had disappeared.
Overall, these analyses illustrate the complexity of neuro-
blastoma tumour cell survival and population expansion after
several different ectopic injections. They also reveal the
specificity and distinctiveness of the tumour progression pro-
perties of this tumour class when compared with those of678 N.R. KLEINMAN et al.
other better-studied tumour classes (Nowell, 1986). Histo-
chemically tagged cells provide the degree of resolution
required to evaluate specific cell and molecular mechanisms
that are operating for or against tumour cell survival and
division in various host tissue environments.
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